Quince Therapeutics
QNCX
#9520
Rank
S$65.28 M
Marketcap
$1.48
Share price
6.13%
Change (1 day)
2.54%
Change (1 year)

EPS for Quince Therapeutics (QNCX)

EPS in 2023 (TTM): -$1.13

According to Quince Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.09. In 2022 the company made an earnings per share (EPS) of -$2.08 an increase over its 2021 EPS that were of -$3.98.

EPS history for Quince Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.13-45.59%
2022-$2.08-47.85%
2021-$3.9815.21%
2020-$3.4662.51%
2019-$2.13179.56%
2018-$0.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.87 162.65%๐Ÿ‡บ๐Ÿ‡ธ USA